NCT01239251终止不适用
Feasibility of Using the GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 8
- 试验地点
- 1
- 主要终点
- Assess the usability of the GlowCap system by patients
研究概览
简要总结
The purpose of this study is to test the ease of using a new device, called the GlowCap that reminds the patient to take their breast cancer hormone pill. The study will collect information about the experience with this device and what the patient thinks of its role in the daily pill taking routine.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Early stage breast cancer patients taking adjuvant endocrine therapy (ie, tamoxifen, anastrozole, letrozole, exemestane).
- •Age ≥ 60 years
- •Must have broadband internet access at home (to enable the base for the system to communicate to the Vitality server).
- •Must have a landline or mobile phone
排除标准
- •Non-English speaking patients
结局指标
主要结局
Assess the usability of the GlowCap system by patients
时间窗: 2 years
\>60 years of age with early stage breast cancer.
次要结局
- Measure the acceptance and satisfaction of the GlowCap reminder system(2 years)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Ostom-i Alert Sensor Quality of Life ValidationOstomyNCT02319434Stanford University20
尚未招募
不适用
Evaluation of a Novel Head-Mounted Device for Glaucoma Testing: A Proof-of-Concept StudyGlaucomaNCT05030714Brennan Eadie120
已完成
不适用
AML Electronic Decision AidAcute Myeloid LeukemiaNCT03442452Duke University20
已完成
不适用
Electronic Warning System for Atrial FibrillationAtrial FibrillationNCT02455102Insel Gruppe AG, University Hospital Bern1,707
进行中（未招募）
不适用
A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk MonitorSepsis BacterialLactate Blood IncreaseInfectious DiseaseSepsisNCT04796285Brigham and Women's Hospital6